The medication's primary benefit in this population is weight loss through appetite suppression rather than direct glucose-lowering effects
In 4-week clinical studies, the average ADHD-RS score was reduced by: 18.3 to 26.7 in children ages 6 to 17 who took Vyvanse, depending on their dose 16.2 to 18.6 in adults who took Vyvanse, depending on their dose 6.2 to 12.8 in children ages 6 to 17 who took a placebo 8.2 in adults who took a placebo Vyvanse was also effective in longer studies in adults and children
To view a copy of this licence, visit About this article Cite this article Shi, Y., Wei, Z., Feng, Y
cuts down on the desire to eat
NovoCare Pharmacy: Self-pay patients may access Wegovy at reduced rates starting around $149/month for the starting dose Patient Assistance Program: May cover full cost for income-eligible patients without insurance
Their combination increases the risk of adverse cardiovascular side effects